Inactive Instrument

News LYSOGENE

Equities

LYS

FR0013233475

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fragile X Syndrome Pipeline, Clinical Trials Studies, Agreements & Collaborations, and Latest News 2023 (Updated)	23-10-10	AQ
Fragile X Syndrome Pipeline, Clinical Trials and NDA Approvals 2023 (Updated)	23-09-18	AQ
Lysogene S.A.(ENXTPA:LYS) dropped from CAC AllShares Index	23-07-06	CI
Lysogene S.A.(ENXTPA:LYS) dropped from Next Biotech Index	23-07-06	CI
Lysogene CFO Assumes Same Role at Mauna Kea Technologies	23-06-14	MT
Lysogene: placed in liquidation and delisted	23-05-29	CF
Lysogene to Delist from Euronext amid Judicial Liquidation	23-05-29	MT
LYSOGENE : Inside Information / News release on accounts, results	23-04-29	PU
Lysogene S.A. Announces Postponement of 2022 Financial Results Release	23-04-29	CI
Lysogene: no takeover bid received for biotech company	23-04-17	CF
Lysogene Fails to Secure Takeover Bid Amid Reorganization	23-04-17	MT
Lysogene: deadline for takeover bids extended	23-03-27	CF
Lysogene: interim CFO confirmed	23-02-06	CF
French Gene Therapy Group Lysogene Makes Ad Interim CFO Permanent	23-02-06	MT
Lysogene Appoints Côme de La Tour du Pin as Chief Financial Officer	23-02-03	CI
Lysogene: company placed in receivership	23-01-25	CF
Lysogene: officially looking for a buyer	23-01-09	CF
Lysogene Seeks Launch of Safeguard Process Amid Financing Woes	22-12-07	MT
LYSOGENE : Inside Information / Operations of the issuer (acquisitions, sales...)	22-12-06	PU
Lysogene : Announces Favorable DSMB Review Recommending Study Continuation and Positive Biomarker Data in Stage 1 of Adaptative Clinical Trial with LYS-GM101 Gene Therapy in GM1 Gangliosidosis	22-11-29	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer